Why Integration is Key to Make The Most of Cutting-Edge Technologies for Rational Drug Design?
Despite numerous new technologies in drug design and discovery, the average number of FDA small-molecule drug approvals has remained flat over the period of two decades.
One of the reasons has been the lack of integration of current technologies in pharma R&D, which is to some extent caused by the legacy systems that cannot communicate to each other and enable the free data flow across multi-disciplinary drug discovery teams, including protein structure data.
The poor exchange between experts from different fields and lack of structural insights can lead to poor decision-making and spending time on working on “wrong” compound.
Integration is key for the discovery
More and more modern software technologies are designed to account for the easy integration in the existing IT ecosystem, lower latency and fast data access with the goal of maximizing success.
3decision is a modern software solution that stores all your 3D protein structures and easily integrates them into the early drug discovery eco-system. It allows biotech and pharma businesses to respond quickly to the collaboration shift and leverage rational drug design.
Powerful API of 3decision allows you and your team to:
Ease structural data sharing and collaboration in the multi-faceted drug discovery environment and ensure the overview of the project progresses in real-time
Embrace flexible approach to drug discovery addressing numerous different use-cases with ideal communication between different tools
Increase efficiency and production of high-quality drug candidates with optimized properties relying on the power of joint modern technologies
The empowerment of data-driven decision making in pharma R&D to speed up the development of next-generation drugs is our mission at Discngine! During 15 years of experience, Discngine has developed effective digital solutions to streamline the early drug design processes and accelerate drug discovery.
Our Mission
Discngine is a Winner of 2019 Bio-IT World Innovative Practices Awards together with Abbvie for the co-development of 3decision®
“We were sitting on these almost 9,000 structures, and except for 2-3 people, nobody else knew where they were.”
- Rishi Gupta, Senior Research Scientist at Abbvie
“The 3decision® site has become a key stopping point for our scientists who design compounds, analyze and share protein structures, and retrieve external and internal protein x-ray and NMR structures.”
- Research Fellow, Discovery Chemistry at Abbvie